Vanda Pharmaceuticals Inc. (LON:0LKB)

Vanda Pharmaceuticals Statistics

Total Valuation

LON:0LKB has a market cap or net worth of GBP 202.66 million. The enterprise value is -30.38 million.

Market Cap	202.66M
Enterprise Value	-30.38M

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	59.09M
Shares Outstanding	n/a
Shares Change (YoY)	+1.34%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	49.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.36
PB Ratio	0.57
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.62
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.63

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.02.

Current Ratio	3.25
Quick Ratio	3.05
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-52.37

Financial Efficiency

Return on equity (ROE) is -13.01% and return on invested capital (ROIC) is -12.01%.

Return on Equity (ROE)	-13.01%
Return on Assets (ROA)	-9.87%
Return on Invested Capital (ROIC)	-12.01%
Return on Capital Employed (ROCE)	-20.03%
Revenue Per Employee	403,561
Profits Per Employee	-132,764
Employee Count	368
Asset Turnover	0.32
Inventory Turnover	6.27

Taxes

Income Tax	-13.18M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.10%
50-Day Moving Average	4.61
200-Day Moving Average	4.62
Relative Strength Index (RSI)	56.71
Average Volume (20 Days)	2,411

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.97

Income Statement

In the last 12 months, LON:0LKB had revenue of GBP 148.51 million and -48.86 million in losses. Loss per share was -0.83.

Revenue	148.51M
Gross Profit	140.19M
Operating Income	-73.58M
Pretax Income	-62.04M
Net Income	-48.86M
EBITDA	-67.79M
EBIT	-73.58M
Loss Per Share	-0.83

Balance Sheet

The company has 237.62 million in cash and 8.49 million in debt, giving a net cash position of 229.12 million.

Cash & Cash Equivalents	237.62M
Total Debt	8.49M
Net Cash	229.12M
Net Cash Per Share	n/a
Equity (Book Value)	354.97M
Book Value Per Share	6.01
Working Capital	199.58M

Cash Flow

In the last 12 months, operating cash flow was -47.30 million and capital expenditures -810,189, giving a free cash flow of -48.11 million.

Operating Cash Flow	-47.30M
Capital Expenditures	-810,189
Free Cash Flow	-48.11M
FCF Per Share	n/a

Margins

Gross margin is 94.40%, with operating and profit margins of -49.55% and -32.90%.

Gross Margin	94.40%
Operating Margin	-49.55%
Pretax Margin	-41.77%
Profit Margin	-32.90%
EBITDA Margin	-45.64%
EBIT Margin	-49.55%
FCF Margin	n/a

Dividends & Yields

LON:0LKB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.34%
Shareholder Yield	n/a
Earnings Yield	-24.11%
FCF Yield	-23.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0LKB has an Altman Z-Score of 1.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.02
Piotroski F-Score	3